Global Point-of-Care Testing Market - Focus on Application, Market Share, Product Mapping and Country - Analysis and Forecast (2017-2026)
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
The global healthcare scenario is witnessing unprecedented epidemiological and demographic changes rapidly. These changes are due to the increasing geriatric population as well as the rising prevalence of diseases. As per the WHO statistics, the global elderly population (aged 65 years and over) was 562 million in 2012 and it rose by 55 million in 2015. The prevalence of various chronic and lifestyle diseases has been increasing as well. It was estimated by WHO that the global prevalence of diabetes increased to 8.5% in adults over the age of 18 years in 2014 from 4.7% in 1980. Thus, the rising prevalence of diseases has led to increased morbidity and mortality thereby increasing the demand for better treatment and diagnostic services. Diagnosis is the very first and important step of treating any ailment. These factors have led to advancement in the field of In-Vitro Diagnostics (IVD). With the advancement of technology, the field of IVD is evolving with the development of various devices which are minimally invasive as well as have better precision and accuracy.
The IVD tests that can be performed at or near the patient site are called as Point Of Care Testing or POCT.
The POCT market includes product types, such as devices/ instruments, accessories/ consumables and software & other solutions. The market consists of various types of devices for different therapeutics application, such as blood glucose monitoring, infectious diseases, blood gas & electrolytes, anticoagulant management, pregnancy & fertility, substance abuse, urinalysis, cardiac markers, lipids, HbA1C, tumor/cancer markers and several others.
These devices are being used for the rapid diagnosis of disease conditions for the early detection and management of the disease. The market analysis includes an in-depth examination of the key ecosystem players, and the key strategies and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges), and industry analysis.
The purpose of the study is to gain a holistic view of the POCT market in terms of various factors influencing it, such as recent trends, technological advancements, and regulatory aspects of the market. The scope of this report is centered upon conducting a detailed study of the solutions allied with the POCT market. The market has been segmented into ‘product’, ‘application’, ‘end users’ and ‘geographical regions’. The report offers the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.
This research report aims at answering questions related to various aspects of the global market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global POCT market, and assesses the factors governing the same.
The answers to the following key questions can be derived from this report:
The global healthcare scenario is witnessing unprecedented epidemiological and demographic changes rapidly. These changes are due to the increasing geriatric population as well as the rising prevalence of diseases. As per the WHO statistics, the global elderly population (aged 65 years and over) was 562 million in 2012 and it rose by 55 million in 2015. The prevalence of various chronic and lifestyle diseases has been increasing as well. It was estimated by WHO that the global prevalence of diabetes increased to 8.5% in adults over the age of 18 years in 2014 from 4.7% in 1980. Thus, the rising prevalence of diseases has led to increased morbidity and mortality thereby increasing the demand for better treatment and diagnostic services. Diagnosis is the very first and important step of treating any ailment. These factors have led to advancement in the field of In-Vitro Diagnostics (IVD). With the advancement of technology, the field of IVD is evolving with the development of various devices which are minimally invasive as well as have better precision and accuracy.
The IVD tests that can be performed at or near the patient site are called as Point Of Care Testing or POCT.
The POCT market includes product types, such as devices/ instruments, accessories/ consumables and software & other solutions. The market consists of various types of devices for different therapeutics application, such as blood glucose monitoring, infectious diseases, blood gas & electrolytes, anticoagulant management, pregnancy & fertility, substance abuse, urinalysis, cardiac markers, lipids, HbA1C, tumor/cancer markers and several others.
These devices are being used for the rapid diagnosis of disease conditions for the early detection and management of the disease. The market analysis includes an in-depth examination of the key ecosystem players, and the key strategies and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges), and industry analysis.
The purpose of the study is to gain a holistic view of the POCT market in terms of various factors influencing it, such as recent trends, technological advancements, and regulatory aspects of the market. The scope of this report is centered upon conducting a detailed study of the solutions allied with the POCT market. The market has been segmented into ‘product’, ‘application’, ‘end users’ and ‘geographical regions’. The report offers the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.
This research report aims at answering questions related to various aspects of the global market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global POCT market, and assesses the factors governing the same.
The answers to the following key questions can be derived from this report:
- What are the major market drivers, challenges, and opportunities in the global POCT market?
- How did the POCT market evolve, and what is its scope in the future?
- What are the market shares of the leading segments, and sub-segments of the global POCT market in 2017 and 2026?
- How will each segment of the global POCT market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2026?
- What are the influencing factors that may affect the market share of the key players?
- What are the key developmental strategies implemented by the key players to stand out in this market?
- What will be the growth rate of the Blood Glucose Monitoring devices during the forecast period?
- Which product segment is expected to register the highest CAGR for the POCT market?
- How has the market been segmented based on application? Which application segment has the largest share, and growth rate in the POCT market?
- What is the growth rate of tumor marker POCT devices/ tests?
- How the homecare segment among end users will grow from 2017 to 2026?
- Which geographical location will contribute to the highest sales of the POCT devices during the forecast period?
EXECUTIVE SUMMARY
1 MARKET OVERVIEW
1.1. Introduction
1.2. IVD-Evolution of Point-of-Care testing
1.3. Traditional vs. Point-Of-Care Testing
1.4. Benefits of POC
1.5. The Present Scenario
1.6. The Future Scenario
2 MARKET DYNAMICS
2.1. Market Drivers
2.2. Market Challenges
2.3. Market Opportunities
3 INDUSTRY INSIGHTS
3.1. Regulatory Scenario
3.2. Patent Landscape
4 COMPETITIVE LANDSCAPE
4.1. Share of Different Strategies
4.2. Porter's Five Force Analysis
4.3. Market Share Analysis
5 GLOBAL POINT-OF-CARE TESTING MARKET, BY PRODUCT
5.1. Introduction
5.2. Products (Devices, Consumables/Accessories and Software & other solutions)
6 GLOBAL POINT OF CARE TESTING MARKET, BY APPLICATION
6.1. Introduction
6.2. Blood Glucose Monitoring Test
6.3. Infectious Diseases Test
6.4. Anticoagulant Management
6.5. Pregnancy & Fertility Testing
6.6. Substance Abuse Test
6.7. Blood Gas & Electrolyte Test
6.8. Urinalysis
6.9. Cardiac Markers
6.10. HbA1C
6.11. Lipids
6.12. Tumor/Cancer Markers
6.13. Others
7 GLOBAL POINT OF CARE TESTING MARKET, BY END USER
7.1. Introduction
7.2. Type of End Users (Hospitals, Clinics, Home Care, Diagnostic Laboratories & others)
8 GLOBAL POINT OF CARE TESTING MARKET, BY REGION
8.1. Introduction
8.2. North America
8.2.1. The U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. Italy
8.3.4. The U.K.
8.3.5. Spain
8.3.6. Netherlands
8.3.7. Belgium
8.3.8. Rest of Europe
8.4. Asia Pacific
8.4.1. Japan
8.4.2. China
8.4.3. Australia
8.4.4. South Korea
8.4.5. India
8.4.6. Rest of Asia Pacific
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Lain America
8.6. Rest of the World (RoW)
8.6.1. MENA
8.6.2. Russia
8.6.3. Rest of RoW
9 COMPANY PROFILES
9.1. Abaxis, Inc.
9.1.1. Overview
9.1.2. Overall Product Portfolio
9.1.3. Product Offerings for POC Market
9.1.4. Financials
9.1.4.1. Financial Summary
9.1.5. Global Presence
9.1.6. Recent Developments
9.1.7. Abaxis Inc.: SWOT Analysis
9.2. Abbott Laboratories
9.2.1. Overview
9.2.2. Overall Product Portfolio
9.2.3. Product Offerings for POC Market
9.2.4. Financials
9.2.4.1. Financial Summary
9.2.5. Global Presence
9.2.6. Recent Developments
9.2.7. Abbott Laboratories: SWOT Analysis
9.3. Alfa Scientific Designs, Inc.
9.3.1. Overview
9.3.2. Corporate Summary
9.3.3. Product Offerings for POC Market
9.3.4. Recent Developments
9.3.5. Alfa Scientific Designs, Inc.: SWOT Analysis
9.4. ARKRAY, Inc.
9.4.1. Overview
9.4.2. Corporate Summary
9.4.3. Product Offerings for POC Market
9.4.4. Recent Developments
9.4.5. ARKRAY, Inc.: SWOT Analysis
9.5. Ascencia Diabetes Care Holdings AG
9.5.1. Overview
9.5.2. Parent Company Overview: Panasonic Healthcare Holdings Co., Ltd.
9.5.3. Corporate Summary
9.5.4. Product Offerings for POC Market
9.5.5. Recent Developments
9.5.6. Ascencia Diabetes Care Holdings AG: SWOT Analysis
9.6. Beckman Coulter
9.6.1. Overview
9.6.2 Parent Company Overview: Danaher Corporation
9.6.3. Overall Product Portfolio: Danaher Corporation
9.6.4. Product Offerings for POC Market
9.6.5. Financials: Danaher Corporation
9.6.5.1. Financial Summary: Danaher Corporation
9.6.6. Global Presence: Danaher Corporation
9.6.7. Recent Developments: Danaher Corporation
9.6.8. Danaher Corporation: SWOT Analysis
9.7. Becton Dickinson and Company
9.7.1. Overview
9.7.2. Overall Product Portfolio
9.7.3. Product Offerings for POC Market
9.7.4. Financials
9.7.4.1. Financial Summary
9.7.5. Global Presence
9.7.6. Recent Developments
9.7.7. Becton Dickinson and Company: SWOT Analysis
9.8. bioMerieux SA
9.8.1. Overview
9.8.2. Overall Product Portfolio
9.8.3. Product Offerings for POC Market
9.8.4. Financials
9.8.4.1. Financial Summary
9.8.5. Global Presence
9.8.6. Recent Developments
9.8.7. bioMerieux SA: SWOT Analysis
9.9. CHEMBIO DIAGNOSTICS, INC.
9.9.1. Overview
9.9.2. Overall Product Portfolio
9.9.3. Product Offerings for POC Market
9.9.4. Financials
9.9.4.1. Financial Summary
9.9.5. Global Presence
9.9.6. Recent Developments
9.9.7. CHEMBIO DIAGNOSTICS, Inc.: SWOT Analysis
9.10. F. Hoffmann-La Roche AG
9.10.1. Overview
9.10.2. Overall Product Portfolio
9.10.3. Product Offerings for POC Market
9.10.4. Financials
9.10.4.1. Financial Summary
9.10.5. Global Presence
9.10.6. Recent Developments
9.10.7. F. Hoffmann-La Roche AG: SWOT Analysis
9.11. Instrumentation Laboratory
9.11.1. Overview
9.11.2. Corporate Summary
9.11.3. Product Offerings for POC Market
9.11.4. Recent Developments
9.11.5. Instrumentation Laboratories: SWOT Analysis
9.12. LamdaGen Corporation
9.12.1. Overview
9.12.2. Corporate Summary
9.12.3. Product Offerings for POC Market
9.12.4. Recent Developments
9.12.5. LamdaGen Corporation: SWOT Analysis
9.13. Medtronic Public Limited Company
9.13.1. Overview
9.13.2. Overall Product Portfolio
9.13.3. Medtronic Public Limited Company: Product Portfolio
9.13.4. Financials
9.13.4.1. Financial Summary
9.13.5. Global Presence
9.13.6. Recent Developments
9.13.7. Medtronic Public Limited Company: SWOT Analysis
9.14. Nova Biomedical
9.14.1. Overview
9.14.2. Corporate Summary
9.14.3. Product Offerings for POC Market
9.14.4. Recent Developments
9.14.5. Nova Biomedical: SWOT Analysis
9.15. OraSure Technologies, Inc.
9.15.1. Overview
9.15.2. Overall Product Portfolio
9.15.3. Product Offerings for POC Market
9.15.4. Financials
9.15.4.1. Financial Summary
9.15.5. Global Presence
9.15.6. Recent Developments
9.15.7. OraSure Technologies, Inc.: SWOT Analysis
9.16. RADIOMETER
9.16.1. Overview
9.16.2. Corporate Summary
9.16.3. Product Offerings for POC Market
9.16.4. Recent Developments
9.16.5. RADIOMETER: SWOT Analysis
9.17. Siemens Healthineers
9.17.1. Overview
9.17.2. Parent Company Overview: Siemens
9.17.3. Overall Product Portfolio of Siemens
9.17.4. Product Offerings for POC Market
9.17.5. Financials (Siemens)
9.17.5.1. Financial Summary (Siemens)
9.17.6. Global Presence (Siemens)
9.17.7. Recent Developments
9.17.8. Siemens: SWOT Analysis
9.18. Trinity Biotech plc
9.18.1. Overview
9.18.2. Overall Product Portfolio
9.18.3. Product Offerings for POC Market
9.18.4. Financials
9.18.4.1. Financial Summary
9.18.5. Global Presence
9.18.6. Recent Developments
9.18.7. Trinity Biotech plc: SWOT Analysis
9.19. CALYPTE BIOMEDICAL CORPORATION
9.19.1. Overview
9.19.2. Product Offerings for POC Market
9.20. LifeScan, Inc.
9.20.1. Overview
9.20.2. Product Offerings for POC Market
9.21. Mologic
9.21.1. Overview
9.21.2. Product Offerings for POC Market
9.22. PTS Diagnostics
9.22.1. Overview
9.22.2. Product Offerings for POC Market
9.23. Sinocare Inc.
9.23.1. Overview
9.23.2. Product Offerings for POC Market
10 REPORT SCOPE
10.1 Scope of the Report
10.2 Global POCT Market Segmentation
10.3 Research Methodology
10.3.1. Data Triangulation
10.3.2. Key Data Points From Secondary Sources
10.3.3. Key Data Points From Primary Sources
10.3.4. Top-Down Approach (Segmental Analysis)
10.3.5. Bottom-Up Approach (Segmental Analysis)
10.3.6. Data and Prediction Modelling
10.4. Assumptions and Limitations
1 MARKET OVERVIEW
1.1. Introduction
1.2. IVD-Evolution of Point-of-Care testing
1.3. Traditional vs. Point-Of-Care Testing
1.4. Benefits of POC
1.5. The Present Scenario
1.6. The Future Scenario
2 MARKET DYNAMICS
2.1. Market Drivers
2.2. Market Challenges
2.3. Market Opportunities
3 INDUSTRY INSIGHTS
3.1. Regulatory Scenario
3.2. Patent Landscape
4 COMPETITIVE LANDSCAPE
4.1. Share of Different Strategies
4.2. Porter's Five Force Analysis
4.3. Market Share Analysis
5 GLOBAL POINT-OF-CARE TESTING MARKET, BY PRODUCT
5.1. Introduction
5.2. Products (Devices, Consumables/Accessories and Software & other solutions)
6 GLOBAL POINT OF CARE TESTING MARKET, BY APPLICATION
6.1. Introduction
6.2. Blood Glucose Monitoring Test
6.3. Infectious Diseases Test
6.4. Anticoagulant Management
6.5. Pregnancy & Fertility Testing
6.6. Substance Abuse Test
6.7. Blood Gas & Electrolyte Test
6.8. Urinalysis
6.9. Cardiac Markers
6.10. HbA1C
6.11. Lipids
6.12. Tumor/Cancer Markers
6.13. Others
7 GLOBAL POINT OF CARE TESTING MARKET, BY END USER
7.1. Introduction
7.2. Type of End Users (Hospitals, Clinics, Home Care, Diagnostic Laboratories & others)
8 GLOBAL POINT OF CARE TESTING MARKET, BY REGION
8.1. Introduction
8.2. North America
8.2.1. The U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. Italy
8.3.4. The U.K.
8.3.5. Spain
8.3.6. Netherlands
8.3.7. Belgium
8.3.8. Rest of Europe
8.4. Asia Pacific
8.4.1. Japan
8.4.2. China
8.4.3. Australia
8.4.4. South Korea
8.4.5. India
8.4.6. Rest of Asia Pacific
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Lain America
8.6. Rest of the World (RoW)
8.6.1. MENA
8.6.2. Russia
8.6.3. Rest of RoW
9 COMPANY PROFILES
9.1. Abaxis, Inc.
9.1.1. Overview
9.1.2. Overall Product Portfolio
9.1.3. Product Offerings for POC Market
9.1.4. Financials
9.1.4.1. Financial Summary
9.1.5. Global Presence
9.1.6. Recent Developments
9.1.7. Abaxis Inc.: SWOT Analysis
9.2. Abbott Laboratories
9.2.1. Overview
9.2.2. Overall Product Portfolio
9.2.3. Product Offerings for POC Market
9.2.4. Financials
9.2.4.1. Financial Summary
9.2.5. Global Presence
9.2.6. Recent Developments
9.2.7. Abbott Laboratories: SWOT Analysis
9.3. Alfa Scientific Designs, Inc.
9.3.1. Overview
9.3.2. Corporate Summary
9.3.3. Product Offerings for POC Market
9.3.4. Recent Developments
9.3.5. Alfa Scientific Designs, Inc.: SWOT Analysis
9.4. ARKRAY, Inc.
9.4.1. Overview
9.4.2. Corporate Summary
9.4.3. Product Offerings for POC Market
9.4.4. Recent Developments
9.4.5. ARKRAY, Inc.: SWOT Analysis
9.5. Ascencia Diabetes Care Holdings AG
9.5.1. Overview
9.5.2. Parent Company Overview: Panasonic Healthcare Holdings Co., Ltd.
9.5.3. Corporate Summary
9.5.4. Product Offerings for POC Market
9.5.5. Recent Developments
9.5.6. Ascencia Diabetes Care Holdings AG: SWOT Analysis
9.6. Beckman Coulter
9.6.1. Overview
9.6.2 Parent Company Overview: Danaher Corporation
9.6.3. Overall Product Portfolio: Danaher Corporation
9.6.4. Product Offerings for POC Market
9.6.5. Financials: Danaher Corporation
9.6.5.1. Financial Summary: Danaher Corporation
9.6.6. Global Presence: Danaher Corporation
9.6.7. Recent Developments: Danaher Corporation
9.6.8. Danaher Corporation: SWOT Analysis
9.7. Becton Dickinson and Company
9.7.1. Overview
9.7.2. Overall Product Portfolio
9.7.3. Product Offerings for POC Market
9.7.4. Financials
9.7.4.1. Financial Summary
9.7.5. Global Presence
9.7.6. Recent Developments
9.7.7. Becton Dickinson and Company: SWOT Analysis
9.8. bioMerieux SA
9.8.1. Overview
9.8.2. Overall Product Portfolio
9.8.3. Product Offerings for POC Market
9.8.4. Financials
9.8.4.1. Financial Summary
9.8.5. Global Presence
9.8.6. Recent Developments
9.8.7. bioMerieux SA: SWOT Analysis
9.9. CHEMBIO DIAGNOSTICS, INC.
9.9.1. Overview
9.9.2. Overall Product Portfolio
9.9.3. Product Offerings for POC Market
9.9.4. Financials
9.9.4.1. Financial Summary
9.9.5. Global Presence
9.9.6. Recent Developments
9.9.7. CHEMBIO DIAGNOSTICS, Inc.: SWOT Analysis
9.10. F. Hoffmann-La Roche AG
9.10.1. Overview
9.10.2. Overall Product Portfolio
9.10.3. Product Offerings for POC Market
9.10.4. Financials
9.10.4.1. Financial Summary
9.10.5. Global Presence
9.10.6. Recent Developments
9.10.7. F. Hoffmann-La Roche AG: SWOT Analysis
9.11. Instrumentation Laboratory
9.11.1. Overview
9.11.2. Corporate Summary
9.11.3. Product Offerings for POC Market
9.11.4. Recent Developments
9.11.5. Instrumentation Laboratories: SWOT Analysis
9.12. LamdaGen Corporation
9.12.1. Overview
9.12.2. Corporate Summary
9.12.3. Product Offerings for POC Market
9.12.4. Recent Developments
9.12.5. LamdaGen Corporation: SWOT Analysis
9.13. Medtronic Public Limited Company
9.13.1. Overview
9.13.2. Overall Product Portfolio
9.13.3. Medtronic Public Limited Company: Product Portfolio
9.13.4. Financials
9.13.4.1. Financial Summary
9.13.5. Global Presence
9.13.6. Recent Developments
9.13.7. Medtronic Public Limited Company: SWOT Analysis
9.14. Nova Biomedical
9.14.1. Overview
9.14.2. Corporate Summary
9.14.3. Product Offerings for POC Market
9.14.4. Recent Developments
9.14.5. Nova Biomedical: SWOT Analysis
9.15. OraSure Technologies, Inc.
9.15.1. Overview
9.15.2. Overall Product Portfolio
9.15.3. Product Offerings for POC Market
9.15.4. Financials
9.15.4.1. Financial Summary
9.15.5. Global Presence
9.15.6. Recent Developments
9.15.7. OraSure Technologies, Inc.: SWOT Analysis
9.16. RADIOMETER
9.16.1. Overview
9.16.2. Corporate Summary
9.16.3. Product Offerings for POC Market
9.16.4. Recent Developments
9.16.5. RADIOMETER: SWOT Analysis
9.17. Siemens Healthineers
9.17.1. Overview
9.17.2. Parent Company Overview: Siemens
9.17.3. Overall Product Portfolio of Siemens
9.17.4. Product Offerings for POC Market
9.17.5. Financials (Siemens)
9.17.5.1. Financial Summary (Siemens)
9.17.6. Global Presence (Siemens)
9.17.7. Recent Developments
9.17.8. Siemens: SWOT Analysis
9.18. Trinity Biotech plc
9.18.1. Overview
9.18.2. Overall Product Portfolio
9.18.3. Product Offerings for POC Market
9.18.4. Financials
9.18.4.1. Financial Summary
9.18.5. Global Presence
9.18.6. Recent Developments
9.18.7. Trinity Biotech plc: SWOT Analysis
9.19. CALYPTE BIOMEDICAL CORPORATION
9.19.1. Overview
9.19.2. Product Offerings for POC Market
9.20. LifeScan, Inc.
9.20.1. Overview
9.20.2. Product Offerings for POC Market
9.21. Mologic
9.21.1. Overview
9.21.2. Product Offerings for POC Market
9.22. PTS Diagnostics
9.22.1. Overview
9.22.2. Product Offerings for POC Market
9.23. Sinocare Inc.
9.23.1. Overview
9.23.2. Product Offerings for POC Market
10 REPORT SCOPE
10.1 Scope of the Report
10.2 Global POCT Market Segmentation
10.3 Research Methodology
10.3.1. Data Triangulation
10.3.2. Key Data Points From Secondary Sources
10.3.3. Key Data Points From Primary Sources
10.3.4. Top-Down Approach (Segmental Analysis)
10.3.5. Bottom-Up Approach (Segmental Analysis)
10.3.6. Data and Prediction Modelling
10.4. Assumptions and Limitations
LIST OF TABLES
1 GLOBAL POCT MARKET (2017 & 2026)
2 TOTAL REGIONAL GERIATRIC POPULATION BY REGION (%), 2015 AND 2030
3 SOME EXAMPLES OF POCT PRODUCTS
4 GLOBAL REGULATORY SCENARIO
5 RISK ASSOCIATED WITH CHOLESTEROL LEVELS
6 SOME OF COMMON CANCER MARKERS
7 PERCENTAGE OF POPULATION AGED 60 YEARS OR ABOVE
8 PERCENTAGES OF POPULATION AGED 60 OR OVER.
9 PERCENTAGES OF POPULATION AGED 60 OR OVER.
10 ABAXIS, INC.:OVERVIEW
11 ABAXIS, INC.: RECENT DEVELOPMENTS
12 ABBOTT LABORATORIES:OVERVIEW
13 ABBOTT LABORATORIES: RECENT DEVELOPMENTS
14 ALFA SCIENTIFIC DESIGNS, INC.:OVERVIEW
15 ALFA SCIENTIFIC DESIGNS, INC: RECENT DEVELOPMENTS
16 ARKRAY, INC.: OVERVIEW
17 ARKRAY, INC: RECENT DEVELOPMENTS
18 ASCENSIA DIABETES CARE HOLDINGS AG.: OVERVIEW
19 ASCENSIA DIABETES CARE HOLDINGS AG: PARENT COMPANY OVERVIEW: PANASONIC HEALTHCARE HOLDINGS CO., LTD.
20 ASCENSIA DIABETES CARE HOLDINGS AG: RECENT DEVELOPMENTS
21 BECKMAN COULTER: OVERVIEW
22 BECKMAN COULTER: PARENT COMPANY OVERVIEW: DANAHER CORPORATION
23 DANAHER CORPORATION: RECENT DEVELOPMENTS
24 BECTON DICKINSON AND COMPANY: OVERVIEW
25 BECTON DICKINSON AND COMPANY: RECENT DEVELOPMENTS
26 BIOMERIEUX SA: OVERVIEW
27 BIOMERIEUX SA: RECENT DEVELOPMENTS
28 CHEMBIO DIAGNOSTICS, INC.: OVERVIEW
29 CHEMBIO DIAGNOSTICS, INC.: RECENT DEVELOPMENTS
30 F.HOFFMANN-LA ROCHE AG: OVERVIEW
31 INSTRUMENTATION LABORATORY: OVERVIEW
32 INSTRUMENTATION LABORATORY: RECENT DEVELOPMENTS
33 MEDTRONIC PUBLIC LIMITED COMPANY: OVERVIEW
34 MEDTRONIC PUBLIC LIMITED COMPANY: RECENT DEVELOPMENTS
35 NOVA BIOMEDICAL: OVERVIEW
36 NOVA BIOMEDICAL: RECENT DEVELOPMENTS
37 ORASURE TECHNOLOGIES: OVERVIEW
38 ORASURE TECHNOLOGIES: RECENT DEVELOPMENTS
39 RADIOMETER: OVERVIEW
40 RADIOMETER: RECENT DEVELOPMENTS
41 SIEMENS HEALTHINEERS:OVERVIEW
42 SIEMENS HEALTHINEERS: PARENT COMPANY OVERVIEW: SIEMENS
43 SIEMENS: RECENT DEVELOPMENTS
44 TRINITY BIOTECH PLC: OVERVIEW
45 TRINITY BIOTECH PLC: RECENT DEVELOPMENTS
46 CALYPTE BIOMEDICAL CORPORATION: OVERVIEW
47 LIFESCAN, INC.: OVERVIEW
48 MOLOGIC: OVERVIEW
49 PTS DIAGNOSTICS:OVERVIEW
50 SINOCARE INC.: OVERVIEW
1 GLOBAL POCT MARKET (2017 & 2026)
2 TOTAL REGIONAL GERIATRIC POPULATION BY REGION (%), 2015 AND 2030
3 SOME EXAMPLES OF POCT PRODUCTS
4 GLOBAL REGULATORY SCENARIO
5 RISK ASSOCIATED WITH CHOLESTEROL LEVELS
6 SOME OF COMMON CANCER MARKERS
7 PERCENTAGE OF POPULATION AGED 60 YEARS OR ABOVE
8 PERCENTAGES OF POPULATION AGED 60 OR OVER.
9 PERCENTAGES OF POPULATION AGED 60 OR OVER.
10 ABAXIS, INC.:OVERVIEW
11 ABAXIS, INC.: RECENT DEVELOPMENTS
12 ABBOTT LABORATORIES:OVERVIEW
13 ABBOTT LABORATORIES: RECENT DEVELOPMENTS
14 ALFA SCIENTIFIC DESIGNS, INC.:OVERVIEW
15 ALFA SCIENTIFIC DESIGNS, INC: RECENT DEVELOPMENTS
16 ARKRAY, INC.: OVERVIEW
17 ARKRAY, INC: RECENT DEVELOPMENTS
18 ASCENSIA DIABETES CARE HOLDINGS AG.: OVERVIEW
19 ASCENSIA DIABETES CARE HOLDINGS AG: PARENT COMPANY OVERVIEW: PANASONIC HEALTHCARE HOLDINGS CO., LTD.
20 ASCENSIA DIABETES CARE HOLDINGS AG: RECENT DEVELOPMENTS
21 BECKMAN COULTER: OVERVIEW
22 BECKMAN COULTER: PARENT COMPANY OVERVIEW: DANAHER CORPORATION
23 DANAHER CORPORATION: RECENT DEVELOPMENTS
24 BECTON DICKINSON AND COMPANY: OVERVIEW
25 BECTON DICKINSON AND COMPANY: RECENT DEVELOPMENTS
26 BIOMERIEUX SA: OVERVIEW
27 BIOMERIEUX SA: RECENT DEVELOPMENTS
28 CHEMBIO DIAGNOSTICS, INC.: OVERVIEW
29 CHEMBIO DIAGNOSTICS, INC.: RECENT DEVELOPMENTS
30 F.HOFFMANN-LA ROCHE AG: OVERVIEW
31 INSTRUMENTATION LABORATORY: OVERVIEW
32 INSTRUMENTATION LABORATORY: RECENT DEVELOPMENTS
33 MEDTRONIC PUBLIC LIMITED COMPANY: OVERVIEW
34 MEDTRONIC PUBLIC LIMITED COMPANY: RECENT DEVELOPMENTS
35 NOVA BIOMEDICAL: OVERVIEW
36 NOVA BIOMEDICAL: RECENT DEVELOPMENTS
37 ORASURE TECHNOLOGIES: OVERVIEW
38 ORASURE TECHNOLOGIES: RECENT DEVELOPMENTS
39 RADIOMETER: OVERVIEW
40 RADIOMETER: RECENT DEVELOPMENTS
41 SIEMENS HEALTHINEERS:OVERVIEW
42 SIEMENS HEALTHINEERS: PARENT COMPANY OVERVIEW: SIEMENS
43 SIEMENS: RECENT DEVELOPMENTS
44 TRINITY BIOTECH PLC: OVERVIEW
45 TRINITY BIOTECH PLC: RECENT DEVELOPMENTS
46 CALYPTE BIOMEDICAL CORPORATION: OVERVIEW
47 LIFESCAN, INC.: OVERVIEW
48 MOLOGIC: OVERVIEW
49 PTS DIAGNOSTICS:OVERVIEW
50 SINOCARE INC.: OVERVIEW
LIST OF FIGURES
1 POINT OF CARE TESTING: PART OF IVD
2 GLOBAL POINT OF CARE TESTING MARKET ($BILLION)
3 MEDICAL DEVICE CONNECTIVITY
4 KEY TRENDS & OPPORTUNITIES FOR FUTURE
5 CHRONIC CONDITIONS: KEY STATISTICS: 2016
6 GLOBAL POCT MARKET, BY PRODUCT, 2017
7 GLOBAL POCT MARKET, BY PRODUCT, 2026
8 GLOBAL POCT MARKET, BY APPLICATION, 2017
9 GLOBAL POCT MARKET, BY APPLICATION, 2026
10 GLOBAL POCT MARKET VALUE, BY REGION, 2017 & 2026 ($BILLION)
11 GLOBAL POCT MARKET, BY REGION, 2017
12 GLOBAL POCT MARKET, BY REGION, 2026
13 TECHNOLOGICAL ADVANCEMENTS
14 KEY PLAYERS OF POCT MARKET
15 FEATURES OF POC DEVICES
16 MARKET SEGMENTATION OF IN VITRO DIAGNOSTICS
17 TRADITIONAL LABORATORY TESTING PROCEDURE
18 ADVANTAGES OF POINT-OF-CARE TESTING
19 END-USERS OF POCT
20 SHARE OF DIFFERENT KEY STRATEGIES
21 PORTER’S FIVE FORCES ANALYSIS
22 TYPES OF PRODUCTS
23 GLOBAL POCT MARKET, BY PRODUCT, 2016-2026, ($ MILLIONS)
24 GLOBAL POINT-OF-CARE TESTING MARKET, BY APPLICATION
25 GLOBAL POINT OF CARE TESTING MARKET, BY APPLICATION, 2017-2026 ($MILLION)
26 TYPES OF DIABETES MELLITUS
27 RISE IN DIABETES CASES
28 GLOBAL BLOOD GLUCOSE MONITORING TEST MARKET, 2017-2026, ($ MILLIONS)
29 GLOBAL INFECTIOUS DISEASES TEST MARKET, 2017-2026, ($ MILLIONS)
30 GLOBAL INFECTIOUS DISEASES TEST MARKET, BY TYPE 2017-2026, ($ MILLIONS)
31 GLOBAL ANTICOAGULANT MANAGEMENT TEST MARKET, 2017-2026, ($ MILLIONS)
32 GLOBAL PREGNANCY & FERTILITY TESTING MARKET, 2017-2026, ($ MILLIONS)
33 GLOBAL SUBSTANCE ABUSE POCT MARKET, 2016-2026, ($ MILLIONS)
34 GLOBAL BLOOD GAS & ELECTROLYTES POCT MARKET, 2017-2026, ($ MILLIONS)
35 GLOBAL URINALYSIS POCT MARKET, 2016-2026, ($ MILLIONS)
36 DEATHS DUE TO CVD
37 GLOBAL CARDIAC MARKERS POCT MARKET, 2017-2026, ($ MILLIONS)
38 GLOBAL HBA1C POCT MARKET, 2017-2026, ($ MILLIONS)
39 GLOBAL LIPIDS POCT MARKET, 2017-2026, ($ MILLIONS)
40 GLOBAL TUMOR/CANCER MARKER POCT MARKET, 2017-2026, ($ MILLIONS)
41 GLOBAL OTHERS POCT MARKET, 2017-2026, ($MILLIONS)
42 DIFFERENT END USERS FOR THE POINT OF CARE TESTING
43 GLOBAL POCT MARKET, BY END USER, 2016-2026, ($ MILLIONS)
44 GLOBAL POINT OF CARE TESTING MARKET, BY REGION
45 GLOBAL POCT MARKET, BY REGION 2016-2025 ($BILLION)
46 NORTH AMERICA POCT MARKET, 2017-2026 ($MILLION)
47 NORTH AMERICA POCT MARKET, BY COUNTRY, 2016-2026 ($MILLION)
48 THE U.S. POCT MARKET, 2016-2025 ($MILLION)
49 CANADA POCT MARKET, 2016-2026 ($MILLION)
50 EUROPE POCT MARKET, 2017-2026 ($MILLION)
51 EUROPE POCT MARKET, BY COUNTRY, 2017-2026 ($MILLION)
52 GERMANY POCT MARKET, 2017-2026 ($MILLION)
53 FRANCE POCT MARKET, 2017-2026 ($MILLION)
54 ITALY POCT MARKET, 2017-2026 ($MILLION)
55 THE U.K. POCT MARKET, 2017-2026 ($MILLION)
56 SPAIN POCT MARKET, 2017-2026 ($MILLION)
57 NETHERLANDS POCT MARKET, 2017-2026 ($MILLION)
58 BELGIUM POCT MARKET, 2017-2026 ($MILLION)
59 REST OF EUROPE POCT MARKET, 2017-2026 ($MILLION)
60 ASIA PACIFIC POCT MARKET, 2017-2026 ($MILLION)
61 ASIA PACIFIC POCT MARKET, BY COUNTRY, 2017-2026 ($MILLION)
62 JAPAN POCT MARKET, 2017-2026 ($MILLION)
63 CHINA POCT MARKET, 2017-2026 ($MILLION)
64 AUSTRALIA POCT MARKET, 2017-2026 ($MILLION)
65 SOUTH KOREA POCT MARKET, 2017-2026 ($MILLION)
66 INDIA POCT MARKET, 2017-2026 ($MILLION)
67 REST OF ASIA PACIFIC POCT MARKET, 2017-2026 ($MILLION)
68 LATIN AMERICA POCT MARKET, 2017-2026 ($MILLION)
69 LATIN AMERICA POCT MARKET, BY COUNTRY, 2017-2026 ($MILLION)
70 PREVALENCE OF DIABETES IN BRAZIL & MEXICO
71 BRAZIL POCT MARKET, 2017-2026 ($MILLION)
72 MEXICO POCT MARKET, 2017-2026 ($MILLION)
73 REST OF LATIN AMERICA POCT MARKET, 2017-2026 ($MILLION)
74 ROW POCT MARKET, 2017-2026 ($MILLION)
75 ROW POCT MARKET, BY COUNTRY, 2017-2026 ($MILLION)
76 RISING PREVALENCE OF DIABETES
77 MENA POCT MARKET, 2017-2026 ($MILLION)
78 RUSSIA POCT MARKET, 2017-2026 ($MILLION)
79 REST OF ROW POCT MARKET, 2017-2026 ($MILLION)
80 ABAXIS, INC.: PRODUCT PORTFOLIO
81 ABAXIS, INC.: PRODUCT PORTFOLIO FOR POC MARKET
82 ABAXIS, INC.: OVERALL FINANCIALS (2014-2017)
83 ABAXIS, INC.: NET REVENUE BY BUSINESS SEGMENT (2014-2017)
84 ABAXIS, INC.: PRODUCT SALES BY REGION (2014-2017)
85 ABAXIS, INC.: GLOBAL PRESENCE
86 ABAXIS, INC.: SWOT ANALYSIS
87 ABBOTT LABORATORIES: PRODUCT PORTFOLIO
88 ABBOTT LABORATORIES: PRODUCT PORTFOLIO FOR POC MARKET
89 ABBOTT LABORATORIES: OVERALL FINANCIALS (2014-2016
90 ABBOTT LABORATORIES: REVENUE BY BUSINESS SEGMENT (2014-2016
91 ABBOTT LABORATORIES: REVENUE BY REGION (2014-2016)
92 ABBOTT LABORATORIES: GLOBAL PRESENCE
93 ABBOTT LABORATORIES: SWOT ANALYSIS
94 ALFA SCIENTIFIC DESIGNS, INC.: OVERALL PRODUCT PORTFOLIO
95 ALFA SCIENTIFIC DESIGNS, INC.: PRODUCT PORTFOLIO FOR POC MARKET
96 ALFA SCIENTIFIC DESIGNS, INC. :SWOT ANALYSIS
97 ARKRAY, INC.: OVERALL PRODUCT PORTFOLIO
98 ARKRAY, INC.: PRODUCT PORTFOLIO FOR POC MARKET
99 ARKRAY, INC : SWOT ANALYSIS
100 ASCENSIA DIABETES CARE HOLDINGS AG: OVERALL PRODUCT PORTFOLIO
101 ASCENSIA DIABETES CARE HOLDINGS AG: PRODUCT PORTFOLIO FOR POC MARKET
102 ASCENSIA DIABETES CARE HOLDINGS AG :SWOT ANALYSIS
103 DANAHER CORPORATION: PRODUCT PORTFOLIO
104 BECKMAN COULTER: PRODUCT PORTFOLIO FOR POC MARKET
105 DANAHER CORPORATION: OVERALL FINANCIALS (2014-2016)
106 DANAHER CORPORATION: REVENUE BY BUSINESS SEGMENTS (2014-2016)
107 DANAHER CORPORATION: REVENUE BY REGION (2014-2016)
108 DANAHER CORPORATION: GLOBAL PRESENCE
109 DANAHER CORPORATION :SWOT ANALYSIS
110 BECTON DICKINSON & COMPANY: PRODUCT PORTFOLIO
111 BECTON DICKINSON AND COMPANY: PRODUCT PORTFOLIO FOR POC MARKET
112 BECTON, DICKINSON AND COMPANY : OVERALL FINANCIALS (2014-2017)
113 BECTON, DICKINSON AND COMPANY: PRODUCT SALES BY REGION (2014-2017)
114 BECTON, DICKINSON AND COMPANY: REVENUE BY BUSINESS SEGMENT (2014-2017)
115 BECTON, DICKINSON AND COMPANY: REVENUE BY SUB-SEGMENT (2014-2017)
116 BECTON DICKINSON AND COMPANY: GLOBAL PRESENCE
117 BECTON DICKINSON AND COMPANY : SWOT ANALYSIS
118 BIOMERIEUX SA: PRODUCT PORTFOLIO
119 BIOMERIEUX SA: PRODUCT PORTFOLIO FOR POC MARKET
120 BIOMERIEUX SA: OVERALL FINANCIALS (2014-2016)
121 BIOMERIEUX SA: REVENUE BY BUSINESS SEGMENT (2014-2016)
122 BIOMЙRIEUX SA: NET REVENUE BY REGION (2014-2016)
123 BIOMERIEUX SA: GLOBAL PRESENCE
124 BIOMERIEUX SA : SWOT ANALYSIS
125 CHEMBIO DIAGNOSTICS, INC.: PRODUCT PORTFOLIO
126 CHEMBIO DIAGNOSTICS, INC.: PRODUCT PORTFOLIO FOR POC MARKET
127 CHEMBIO DIAGNOSTIC SYSTEMS, INC.: OVERALL FINANCIALS (2014-2016)
128 CHEMBIO DIAGNOSTIC SYSTEMS, INC.: PRODUCT SALES BY REGION (2014-2016)
129 CHEMBIO DIAGNOSTICS, INC.: GLOBAL PRESENCE
130 CHEMBIO DIAGNOSTICS, INC. SWOT ANALYSIS
131 F.HOFFMANN-LA ROCHE AG: PRODUCT PORTFOLIO
132 F. HOFFMANN-LA ROCHE AG: PRODUCT PORTFOLIO FOR POC MARKET
133 F.HOFFMANN-LA ROCHE AG : OVERALL FINANCIALS (2014-2017)
134 F.HOFFMANN-LA ROCHE AG : PRODUCT SALES BY REGION (2014-2017)
135 F.HOFFMANN-LA ROCHE AG: REVENUE BY DIVISION (2014-2017)
136 F.HOFFMANN-LA ROCHE AG: REVENUE BY DIAGNOSTICS SUB-DIVISION (2014-2017)
137 F. HOFFMANN-LA ROCHE AG: GLOBAL PRESENCE
138 F. HOFFMANN-LA ROCHE AG: RECENT DEVELOPMENTS
139 F. HOFFMANN-LA ROCHE AG: SWOT ANALYSIS
140 INSTRUMENTATION LABORATORY: OVERALL PRODUCT PORTFOLIO
141 INSTRUMENTATION LABORATORY: PRODUCT PORTFOLIO FOR POC MARKET
142 MEDTRONIC PUBLIC LIMITED COMPANY: OVERALL PRODUCT PORTFOLIO
143 MEDTRONIC PUBLIC LIMITED COMPANY: PRODUCT PORTFOLIO FOR POC MARKET
144 MEDTRONIC PLC: OVERALL FINANCIALS (2014-2017)
145 MEDTRONIC PLC: NET REVENUE BY BUSINESS SEGMENT (2014-2017)
146 MEDTRONIC PLC: NET REVENUE BY REGION (2014-2017)
147 MEDTRONIC PUBLIC LIMITED COMPANY: GLOBAL PRESENCE
148 MEDTRONIC PUBLIC LIMITED COMPANY: SWOT ANALYSIS
149 NOVA BIOMEDICAL: OVERALL PRODUCT PORTFOLIO
150 NOVA BIOMEDICAL: PRODUCT PORTFOLIO FOR POC MARKET
151 NOVA BIOMEDICAL : SWOT ANALYSIS
152 ORASURE TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
153 ORASURE TECHNOLOGIES, INC.: PRODUCT PORTFOLIO FOR POC MARKET
154 ORASURE TECHNOLOGIES, INC.: OVERALL FINANCIALS (2014-2016)
155 ORASURE TECHNOLOGIES, INC.: NET REVENUE BY BUSINESS SEGMENT (2014-2016)
156 ORASURE TECHNOLGIES, INC.: PRODUCT SALES BY REGION (2015-2017)
157 ORASURE TECHNOLOGIES, INC.: GLOBAL PRESENCE
158 ORASURE TECHNOLOGIES: SWOT ANALYSIS
159 RADIOMETER: OVERALL PRODUCT PORTFOLIO
160 RADIOMETER: PRODUCT PORTFOLIO FOR POC MARKET
161 RADIOMETER : SWOT ANALYSIS
162 SIEMENS: PRODUCT PORTFOLIO
163 PRODUCT PORTFOLIO OF SIEMENS HEALTHINEERS FOR POC MARKET
164 SIEMENS : OVERALL FINANCIALS (2014-2017)
165 SIEMENS: PRODUCT SALES BY REGION (2014-2017)
166 SIEMENS, INC.: NET REVENUE BY BUSINESS SEGMENT (2014-2017)
167 SIEMENS HEALTHINEERS: GLOBAL PRESENCE
168 SIEMENS: SWOT ANALYSIS
169 TRINITY BIOTECH PLC: PRODUCT PORTFOLIO
170 TRINITY BIOTECH PLC: PRODUCT PORTFOLIO FOR POC MARKET
171 TRINITY BIOTECH PLC: OVERALL FINANCIALS (2014-2016)
172 TRINITY BIOTECH PLC: NET REVENUE BY PRODUCT LINE (2014-2016)
173 TRINITY BIOTECH PLC: PRODUCT SALES BY REGION (2014-2016)
174 TRINITY BIOTECH PLC: GLOBAL PRESENCE
175 TRINITY BIOTECH PLC: SWOT ANALYSIS
176 CALYPTE BIOMEDICAL CORPORATION: PRODUCT PORTFOLIO
177 LIFESCAN, INC.: PRODUCT PORTFOLIO
178 MOLOGIC: PRODUCT PORTFOLIO
179 PTS DIAGNOSTICS: PRODUCT PORTFOLIO
180 SINOCARE INC.: PRODUCT PORTFOLIO
181 GLOBAL POCT MARKET SEGMENTATION
1 POINT OF CARE TESTING: PART OF IVD
2 GLOBAL POINT OF CARE TESTING MARKET ($BILLION)
3 MEDICAL DEVICE CONNECTIVITY
4 KEY TRENDS & OPPORTUNITIES FOR FUTURE
5 CHRONIC CONDITIONS: KEY STATISTICS: 2016
6 GLOBAL POCT MARKET, BY PRODUCT, 2017
7 GLOBAL POCT MARKET, BY PRODUCT, 2026
8 GLOBAL POCT MARKET, BY APPLICATION, 2017
9 GLOBAL POCT MARKET, BY APPLICATION, 2026
10 GLOBAL POCT MARKET VALUE, BY REGION, 2017 & 2026 ($BILLION)
11 GLOBAL POCT MARKET, BY REGION, 2017
12 GLOBAL POCT MARKET, BY REGION, 2026
13 TECHNOLOGICAL ADVANCEMENTS
14 KEY PLAYERS OF POCT MARKET
15 FEATURES OF POC DEVICES
16 MARKET SEGMENTATION OF IN VITRO DIAGNOSTICS
17 TRADITIONAL LABORATORY TESTING PROCEDURE
18 ADVANTAGES OF POINT-OF-CARE TESTING
19 END-USERS OF POCT
20 SHARE OF DIFFERENT KEY STRATEGIES
21 PORTER’S FIVE FORCES ANALYSIS
22 TYPES OF PRODUCTS
23 GLOBAL POCT MARKET, BY PRODUCT, 2016-2026, ($ MILLIONS)
24 GLOBAL POINT-OF-CARE TESTING MARKET, BY APPLICATION
25 GLOBAL POINT OF CARE TESTING MARKET, BY APPLICATION, 2017-2026 ($MILLION)
26 TYPES OF DIABETES MELLITUS
27 RISE IN DIABETES CASES
28 GLOBAL BLOOD GLUCOSE MONITORING TEST MARKET, 2017-2026, ($ MILLIONS)
29 GLOBAL INFECTIOUS DISEASES TEST MARKET, 2017-2026, ($ MILLIONS)
30 GLOBAL INFECTIOUS DISEASES TEST MARKET, BY TYPE 2017-2026, ($ MILLIONS)
31 GLOBAL ANTICOAGULANT MANAGEMENT TEST MARKET, 2017-2026, ($ MILLIONS)
32 GLOBAL PREGNANCY & FERTILITY TESTING MARKET, 2017-2026, ($ MILLIONS)
33 GLOBAL SUBSTANCE ABUSE POCT MARKET, 2016-2026, ($ MILLIONS)
34 GLOBAL BLOOD GAS & ELECTROLYTES POCT MARKET, 2017-2026, ($ MILLIONS)
35 GLOBAL URINALYSIS POCT MARKET, 2016-2026, ($ MILLIONS)
36 DEATHS DUE TO CVD
37 GLOBAL CARDIAC MARKERS POCT MARKET, 2017-2026, ($ MILLIONS)
38 GLOBAL HBA1C POCT MARKET, 2017-2026, ($ MILLIONS)
39 GLOBAL LIPIDS POCT MARKET, 2017-2026, ($ MILLIONS)
40 GLOBAL TUMOR/CANCER MARKER POCT MARKET, 2017-2026, ($ MILLIONS)
41 GLOBAL OTHERS POCT MARKET, 2017-2026, ($MILLIONS)
42 DIFFERENT END USERS FOR THE POINT OF CARE TESTING
43 GLOBAL POCT MARKET, BY END USER, 2016-2026, ($ MILLIONS)
44 GLOBAL POINT OF CARE TESTING MARKET, BY REGION
45 GLOBAL POCT MARKET, BY REGION 2016-2025 ($BILLION)
46 NORTH AMERICA POCT MARKET, 2017-2026 ($MILLION)
47 NORTH AMERICA POCT MARKET, BY COUNTRY, 2016-2026 ($MILLION)
48 THE U.S. POCT MARKET, 2016-2025 ($MILLION)
49 CANADA POCT MARKET, 2016-2026 ($MILLION)
50 EUROPE POCT MARKET, 2017-2026 ($MILLION)
51 EUROPE POCT MARKET, BY COUNTRY, 2017-2026 ($MILLION)
52 GERMANY POCT MARKET, 2017-2026 ($MILLION)
53 FRANCE POCT MARKET, 2017-2026 ($MILLION)
54 ITALY POCT MARKET, 2017-2026 ($MILLION)
55 THE U.K. POCT MARKET, 2017-2026 ($MILLION)
56 SPAIN POCT MARKET, 2017-2026 ($MILLION)
57 NETHERLANDS POCT MARKET, 2017-2026 ($MILLION)
58 BELGIUM POCT MARKET, 2017-2026 ($MILLION)
59 REST OF EUROPE POCT MARKET, 2017-2026 ($MILLION)
60 ASIA PACIFIC POCT MARKET, 2017-2026 ($MILLION)
61 ASIA PACIFIC POCT MARKET, BY COUNTRY, 2017-2026 ($MILLION)
62 JAPAN POCT MARKET, 2017-2026 ($MILLION)
63 CHINA POCT MARKET, 2017-2026 ($MILLION)
64 AUSTRALIA POCT MARKET, 2017-2026 ($MILLION)
65 SOUTH KOREA POCT MARKET, 2017-2026 ($MILLION)
66 INDIA POCT MARKET, 2017-2026 ($MILLION)
67 REST OF ASIA PACIFIC POCT MARKET, 2017-2026 ($MILLION)
68 LATIN AMERICA POCT MARKET, 2017-2026 ($MILLION)
69 LATIN AMERICA POCT MARKET, BY COUNTRY, 2017-2026 ($MILLION)
70 PREVALENCE OF DIABETES IN BRAZIL & MEXICO
71 BRAZIL POCT MARKET, 2017-2026 ($MILLION)
72 MEXICO POCT MARKET, 2017-2026 ($MILLION)
73 REST OF LATIN AMERICA POCT MARKET, 2017-2026 ($MILLION)
74 ROW POCT MARKET, 2017-2026 ($MILLION)
75 ROW POCT MARKET, BY COUNTRY, 2017-2026 ($MILLION)
76 RISING PREVALENCE OF DIABETES
77 MENA POCT MARKET, 2017-2026 ($MILLION)
78 RUSSIA POCT MARKET, 2017-2026 ($MILLION)
79 REST OF ROW POCT MARKET, 2017-2026 ($MILLION)
80 ABAXIS, INC.: PRODUCT PORTFOLIO
81 ABAXIS, INC.: PRODUCT PORTFOLIO FOR POC MARKET
82 ABAXIS, INC.: OVERALL FINANCIALS (2014-2017)
83 ABAXIS, INC.: NET REVENUE BY BUSINESS SEGMENT (2014-2017)
84 ABAXIS, INC.: PRODUCT SALES BY REGION (2014-2017)
85 ABAXIS, INC.: GLOBAL PRESENCE
86 ABAXIS, INC.: SWOT ANALYSIS
87 ABBOTT LABORATORIES: PRODUCT PORTFOLIO
88 ABBOTT LABORATORIES: PRODUCT PORTFOLIO FOR POC MARKET
89 ABBOTT LABORATORIES: OVERALL FINANCIALS (2014-2016
90 ABBOTT LABORATORIES: REVENUE BY BUSINESS SEGMENT (2014-2016
91 ABBOTT LABORATORIES: REVENUE BY REGION (2014-2016)
92 ABBOTT LABORATORIES: GLOBAL PRESENCE
93 ABBOTT LABORATORIES: SWOT ANALYSIS
94 ALFA SCIENTIFIC DESIGNS, INC.: OVERALL PRODUCT PORTFOLIO
95 ALFA SCIENTIFIC DESIGNS, INC.: PRODUCT PORTFOLIO FOR POC MARKET
96 ALFA SCIENTIFIC DESIGNS, INC. :SWOT ANALYSIS
97 ARKRAY, INC.: OVERALL PRODUCT PORTFOLIO
98 ARKRAY, INC.: PRODUCT PORTFOLIO FOR POC MARKET
99 ARKRAY, INC : SWOT ANALYSIS
100 ASCENSIA DIABETES CARE HOLDINGS AG: OVERALL PRODUCT PORTFOLIO
101 ASCENSIA DIABETES CARE HOLDINGS AG: PRODUCT PORTFOLIO FOR POC MARKET
102 ASCENSIA DIABETES CARE HOLDINGS AG :SWOT ANALYSIS
103 DANAHER CORPORATION: PRODUCT PORTFOLIO
104 BECKMAN COULTER: PRODUCT PORTFOLIO FOR POC MARKET
105 DANAHER CORPORATION: OVERALL FINANCIALS (2014-2016)
106 DANAHER CORPORATION: REVENUE BY BUSINESS SEGMENTS (2014-2016)
107 DANAHER CORPORATION: REVENUE BY REGION (2014-2016)
108 DANAHER CORPORATION: GLOBAL PRESENCE
109 DANAHER CORPORATION :SWOT ANALYSIS
110 BECTON DICKINSON & COMPANY: PRODUCT PORTFOLIO
111 BECTON DICKINSON AND COMPANY: PRODUCT PORTFOLIO FOR POC MARKET
112 BECTON, DICKINSON AND COMPANY : OVERALL FINANCIALS (2014-2017)
113 BECTON, DICKINSON AND COMPANY: PRODUCT SALES BY REGION (2014-2017)
114 BECTON, DICKINSON AND COMPANY: REVENUE BY BUSINESS SEGMENT (2014-2017)
115 BECTON, DICKINSON AND COMPANY: REVENUE BY SUB-SEGMENT (2014-2017)
116 BECTON DICKINSON AND COMPANY: GLOBAL PRESENCE
117 BECTON DICKINSON AND COMPANY : SWOT ANALYSIS
118 BIOMERIEUX SA: PRODUCT PORTFOLIO
119 BIOMERIEUX SA: PRODUCT PORTFOLIO FOR POC MARKET
120 BIOMERIEUX SA: OVERALL FINANCIALS (2014-2016)
121 BIOMERIEUX SA: REVENUE BY BUSINESS SEGMENT (2014-2016)
122 BIOMЙRIEUX SA: NET REVENUE BY REGION (2014-2016)
123 BIOMERIEUX SA: GLOBAL PRESENCE
124 BIOMERIEUX SA : SWOT ANALYSIS
125 CHEMBIO DIAGNOSTICS, INC.: PRODUCT PORTFOLIO
126 CHEMBIO DIAGNOSTICS, INC.: PRODUCT PORTFOLIO FOR POC MARKET
127 CHEMBIO DIAGNOSTIC SYSTEMS, INC.: OVERALL FINANCIALS (2014-2016)
128 CHEMBIO DIAGNOSTIC SYSTEMS, INC.: PRODUCT SALES BY REGION (2014-2016)
129 CHEMBIO DIAGNOSTICS, INC.: GLOBAL PRESENCE
130 CHEMBIO DIAGNOSTICS, INC. SWOT ANALYSIS
131 F.HOFFMANN-LA ROCHE AG: PRODUCT PORTFOLIO
132 F. HOFFMANN-LA ROCHE AG: PRODUCT PORTFOLIO FOR POC MARKET
133 F.HOFFMANN-LA ROCHE AG : OVERALL FINANCIALS (2014-2017)
134 F.HOFFMANN-LA ROCHE AG : PRODUCT SALES BY REGION (2014-2017)
135 F.HOFFMANN-LA ROCHE AG: REVENUE BY DIVISION (2014-2017)
136 F.HOFFMANN-LA ROCHE AG: REVENUE BY DIAGNOSTICS SUB-DIVISION (2014-2017)
137 F. HOFFMANN-LA ROCHE AG: GLOBAL PRESENCE
138 F. HOFFMANN-LA ROCHE AG: RECENT DEVELOPMENTS
139 F. HOFFMANN-LA ROCHE AG: SWOT ANALYSIS
140 INSTRUMENTATION LABORATORY: OVERALL PRODUCT PORTFOLIO
141 INSTRUMENTATION LABORATORY: PRODUCT PORTFOLIO FOR POC MARKET
142 MEDTRONIC PUBLIC LIMITED COMPANY: OVERALL PRODUCT PORTFOLIO
143 MEDTRONIC PUBLIC LIMITED COMPANY: PRODUCT PORTFOLIO FOR POC MARKET
144 MEDTRONIC PLC: OVERALL FINANCIALS (2014-2017)
145 MEDTRONIC PLC: NET REVENUE BY BUSINESS SEGMENT (2014-2017)
146 MEDTRONIC PLC: NET REVENUE BY REGION (2014-2017)
147 MEDTRONIC PUBLIC LIMITED COMPANY: GLOBAL PRESENCE
148 MEDTRONIC PUBLIC LIMITED COMPANY: SWOT ANALYSIS
149 NOVA BIOMEDICAL: OVERALL PRODUCT PORTFOLIO
150 NOVA BIOMEDICAL: PRODUCT PORTFOLIO FOR POC MARKET
151 NOVA BIOMEDICAL : SWOT ANALYSIS
152 ORASURE TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
153 ORASURE TECHNOLOGIES, INC.: PRODUCT PORTFOLIO FOR POC MARKET
154 ORASURE TECHNOLOGIES, INC.: OVERALL FINANCIALS (2014-2016)
155 ORASURE TECHNOLOGIES, INC.: NET REVENUE BY BUSINESS SEGMENT (2014-2016)
156 ORASURE TECHNOLGIES, INC.: PRODUCT SALES BY REGION (2015-2017)
157 ORASURE TECHNOLOGIES, INC.: GLOBAL PRESENCE
158 ORASURE TECHNOLOGIES: SWOT ANALYSIS
159 RADIOMETER: OVERALL PRODUCT PORTFOLIO
160 RADIOMETER: PRODUCT PORTFOLIO FOR POC MARKET
161 RADIOMETER : SWOT ANALYSIS
162 SIEMENS: PRODUCT PORTFOLIO
163 PRODUCT PORTFOLIO OF SIEMENS HEALTHINEERS FOR POC MARKET
164 SIEMENS : OVERALL FINANCIALS (2014-2017)
165 SIEMENS: PRODUCT SALES BY REGION (2014-2017)
166 SIEMENS, INC.: NET REVENUE BY BUSINESS SEGMENT (2014-2017)
167 SIEMENS HEALTHINEERS: GLOBAL PRESENCE
168 SIEMENS: SWOT ANALYSIS
169 TRINITY BIOTECH PLC: PRODUCT PORTFOLIO
170 TRINITY BIOTECH PLC: PRODUCT PORTFOLIO FOR POC MARKET
171 TRINITY BIOTECH PLC: OVERALL FINANCIALS (2014-2016)
172 TRINITY BIOTECH PLC: NET REVENUE BY PRODUCT LINE (2014-2016)
173 TRINITY BIOTECH PLC: PRODUCT SALES BY REGION (2014-2016)
174 TRINITY BIOTECH PLC: GLOBAL PRESENCE
175 TRINITY BIOTECH PLC: SWOT ANALYSIS
176 CALYPTE BIOMEDICAL CORPORATION: PRODUCT PORTFOLIO
177 LIFESCAN, INC.: PRODUCT PORTFOLIO
178 MOLOGIC: PRODUCT PORTFOLIO
179 PTS DIAGNOSTICS: PRODUCT PORTFOLIO
180 SINOCARE INC.: PRODUCT PORTFOLIO
181 GLOBAL POCT MARKET SEGMENTATION
